Results 61 to 70 of about 2,785 (150)

Antiemetic efficacy of high-dose hydrocortisone in patients receiving cisplatin therapy [PDF]

open access: yes, 1986
Cisplatin療法にhydrocortisone succinateを使用し, 消化器合併症を4段階評価で査定した.1) Cisplatin 7~20 mg/m2/日×5日間を中心とする多剤併用療法にhydrocortisone 900~1, 800 mg/日を使用した場合, 嘔気, 嘔吐回数, 食欲不振の症状は有意に軽減した.2) Cisplatin 30~40 mg/m2/日×1日を中心とする多剤併用療法では, hydrocortisone 1, 500~2, 400 mgの使用は ...
坂田, 安之輔   +4 more
core  

CAPS在膀胱癌患者尿液中的表达及意义

open access: yesZhongguo shiyan zhenduanxue
膀胱癌具有较高的发病率和死亡率[1]。目前临床上膀胱癌最可靠的诊断方法是膀胱镜检查,但这种侵入性检查容易造成微小肿瘤病灶的漏诊[2]。随着液相色谱-质谱联用(LC-MS/MS)技术的广泛应用,寻找诊断膀胱癌的蛋白标志物有了可能。本实验采用LC-MS/MS技术,研究钙磷蛋白(Calcyphosine, CAPS)在膀胱癌患者尿液中的表达水平,旨在为膀胱癌筛查提供一种新的方法。
薛菲, 李婷淼, 岳斯琦, 何成彦
doaj  

[Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2023
Liu HR, Peng X, Li SL, Gou X.
europepmc   +1 more source

Transitional cell carcinoma of the ureter with inverted proliferation accompanied with papillary bladder tumor: a case report [PDF]

open access: yes, 2001
85歳女.右側腹部痛と肉眼的血尿を主訴とした.超音波検査では右尿管は全長にわたり拡張し, 下部尿管内に腫瘤を認めた.骨盤CTでも下部尿管内腫瘍が認められたが尿管外への浸潤はなかった.経尿道的膀胱腫瘍切除術を行った後, 右腎尿管全摘, 膀胱部分切除術を施行した.病理組織所見から, 乳頭状膀胱癌を伴った内反型尿管移行上皮癌であったが, 多発した移行上皮癌が異なる増殖形態をとり得ることを示す症例と考えられたAn 85-year-old female was referred to our hospital ...
小林, 剛   +4 more
core  

Construction of prognosis model of bladder cancer based on transcriptome. [PDF]

open access: yesZhejiang Da Xue Xue Bao Yi Xue Ban, 2022
Chen Q, Cai L, Liang J.
europepmc   +1 more source

A case of pneumocystis carinii pneumonia after chemotherapy of bladder tumor [PDF]

open access: yes, 1985
This is a case report on a 70-year-old male patient. During chemotherapy treatment after a bladder tumor operation, the patient had a complication of pneumonia which did not respond to various antibiotics.
佐々木, 進   +3 more
core  

负性共刺激分子PD-L1在非肌层浸润性膀胱癌的表达 及其对术后膀胱灌注治疗的影响

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2015
【目的】 探讨负性共刺激分子PD-L1在非肌层浸润性膀胱癌的表达及其对术后膀胱灌注治疗的影响? 【方法】采用免疫组化法染色方法检测131例膀胱癌组织标本(均经病理诊断确认为非肌层浸润性膀胱癌)和10例正常膀胱黏膜组织标本的PD-L1表达情况,所有膀胱癌患者术后均予表柔比星或沙培林膀胱灌注,详细记录肿瘤复发?进展的时间和预后情况?【结果】 PD-L1在正常膀胱黏膜组织不表达0(0/10),在非肌层浸润性膀胱癌组织阳性率为56.5%(74/131),P=0.000?PD-L1的表达与病理分期相关,pTa ...
doaj  

Home - About - Disclaimer - Privacy